Switch to:
PDL BioPharma Inc (NAS:PDLI)
Interest Coverage
16.93 (As of Sep. 2014)

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company’s Operating Income (EBIT) by its Interest Expense. PDL BioPharma Inc's Operating Income for the three months ended in Sep. 2014 was $158.9 Mil. PDL BioPharma Inc's Interest Expense for the three months ended in Sep. 2014 was $-9.4 Mil. PDL BioPharma Inc's interest coverage for the quarter that ended in Sep. 2014 was 16.93. The higher the ratio, the stronger the company’s financial strength is.

PDLI' s 10-Year Interest Coverage Range
Min: 1.29   Max: 9999.99
Current: 16.39

1.29
9999.99

During the past 13 years, the highest interest coverage of PDL BioPharma Inc was 9999.99. The lowest was 1.29. And the median was 16.73.

PDLI's Interest Coverageis ranked higher than
53% of the 574 Companies
in the Global Biotechnology industry.

( Industry Median: 10000.00 vs. PDLI: 16.39 )

Definition

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company’s Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1*Operating Income/Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

PDL BioPharma Inc did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt is 0, or Interest Expense is positive, then

PDL BioPharma Inc had no debt.

PDL BioPharma Inc's Interest Coverage for the fiscal year that ended in Dec. 2013 is calculated as

Here, for the fiscal year that ended in Dec. 2013, PDL BioPharma Inc's Interest Expense was $-24.9 Mil. Its Operating Income was $407.5 Mil. And its Long-Term Debt was $0.0 Mil.

Interest Coverage=-1*Operating Income (A: Dec. 2013 )/Interest Expense (A: Dec. 2013 )
=-1*407.529/-24.871
=16.39

PDL BioPharma Inc's Interest Coverage for the quarter that ended in Sep. 2014 is calculated as

Here, for the three months ended in Sep. 2014, PDL BioPharma Inc's Interest Expense was $-9.4 Mil. Its Operating Income was $158.9 Mil. And its Long-Term Debt was $274.5 Mil.

Interest Coverage=-1*Operating Income (Q: Sep. 2014 )/Interest Expense (Q: Sep. 2014 )
=-1*158.908/-9.387
=16.93

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

The higher the ratio, the stronger the company’s financial strength is.


Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company’s overage financial strength.


Related Terms

Operating Income, Interest Expense, Financial Strength


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

PDL BioPharma Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
interest_coverage At LossAt LossAt LossAt Loss17.0715.354.859.5212.0216.39

PDL BioPharma Inc Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
interest_coverage 15.3412.2213.1614.1123.4215.0812.7011.7015.8116.93
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK